Key result
Intermittent low-concentration NBCA embolization achieves 100% complete occlusion without microcatheter entrapment.
Why the study?
The safety and efficacy of low-concentration n-butyl-2-cyanoacrylate embolization using an intermittent injection technique for ruptured or progressively enlarging infectious intracranial aneurysms needed evaluation.
Does low-concentration n-butyl-2-cyanoacrylate (14%) embolization using an intermittent injection technique safely achieve complete angiographic occlusion in patients with ruptured or progressively enlarging infectious intracranial aneurysms?
Observational (n=9)
No
Does low-concentration n-butyl-2-cyanoacrylate (14%) embolization using an intermittent injection technique safely achieve complete angiographic occlusion in patients with ruptured or progressively enlarging infectious intracranial aneurysms?
Low-concentration (14%) NBCA embolization using an intermittent injection technique achieved 100% complete angiographic occlusion without microcatheter entrapment or neurological worsening in a small cohort of patients with infectious intracranial aneurysms.
Answers are grounded in this paper and cite their sources.
Supports feasibility of low-concentration NBCA intermittent embolization in small infectious aneurysm series; leaves open need for prospective validation before adoption.
Background: Endovascular treatment has emerged as a primary therapeutic option for infectious intracranial aneurysms (IIAs), a serious complication of infective endocarditis. At our institution, low-concentration n-butyl-2-cyanoacrylate (NBCA) has been used for ruptured or progressively enlarging IIAs because its prolonged polymerization time allows controlled delivery using an intermittent injection technique while reducing the risk of microcatheter entrapment. We describe this technique and evaluate the safety and efficacy of NBCA for IIAs. Methods: We retrospectively analyzed patients with IIAs treated using low-concentration NBCA (14%) between April 2019 and July 2025 at a single center. Embolization was performed using an intermittent injection technique consisting of cycles of injection, pause, and reassessment to control NBCA progression and limit reflux. Results: Nine patients underwent 10 procedures. The treated lesions involved the middle cerebral artery in seven procedures, the anterior cerebral artery in two, and the posterior cerebral artery in one. Median aneurysm diameter was 2.0 mm (range, 1.4–3.2 mm). Median NBCA volume was 0.03 mL (range, 0.01–0.06 mL), median number of injection pauses was 3 (range, 0–6), and median total injection time was 131 s (range, 21–241 s). Complete angiographic occlusion without microcatheter entrapment was achieved in all procedures. No patient experienced worsening of modified Rankin scale scores after treatment. Conclusion: Low-concentration NBCA embolization using an intermittent injection technique appears safe and effective for ruptured or progressively enlarging IIAs. This approach enables controlled NBCA delivery with repeated pauses, facilitating complete occlusion of both the aneurysm and the parent artery while minimizing reflux and unintended migration.
No takes yet. Share an insight, caveat, or question.
Kohta et al. (2026) conducted an observational in Infectious intracranial aneurysms (IIAs) (n=9). Low-concentration n-butyl-2-cyanoacrylate (NBCA) embolization using an intermittent injection technique was evaluated on Complete angiographic occlusion without microcatheter entrapment. Low-concentration NBCA embolization using an intermittent injection technique achieved 100% complete angiographic occlusion without microcatheter entrapment or mRS worsening across 10 procedures.
Synapse has enriched 10 related papers. Consider them for comparative context: